FAKTOR-OPTIONSSCHEIN - IPSEN | Market Closed - Börse Stuttgart 14:47:40 2024-05-17 EDT | ||
| 5.8 EUR | +0.87% |
|
| Current month | -27.41% | ||
| 1 month | -50.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 5.8 | +0.87% |
| 24-05-16 | 5.75 | -0.17% |
| 24-05-15 | 5.76 | +2.49% |
| 24-05-14 | 5.62 | -11.08% |
| 24-05-13 | 6.32 | +3.95% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 02:47 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG1K9Y |
| ISIN | DE000MG1K9Y4 |
| Date issued | 2024-04-03 |
| Strike | 145.7 € |
| Maturity | Unlimited |
| Parity | 4.27 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.52 € |
|---|---|
| Lowest since issue | 5.48 € |
| Spread | 0.21 € |
| Spread % | 3.52% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.8
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.58%
- Stock Market
- Certificates
- Certificat